Standout Papers

The Revised CONSORT Statement for Reporting Randomized Trials: Ex... 1990 2026 2002 2014 2.8k
  1. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)
    D G Altman et al. Annals of Internal Medicine
  2. Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors (1994)
    D G Altman, Berthold Lausen et al. JNCI Journal of the National Cancer Institute
  3. Analysis of serial measurements in medical research. (1990)
    J. N. S. Matthews, D G Altman et al. BMJ

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 84 standout
Sub-graph 1 of 16

Citing Papers

Lack of group-to-individual generalizability is a threat to human subjects research
2018 Standout
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
2016 Standout
1 intermediate paper

Works of D G Altman being referenced

The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Analysis of serial measurements in medical research.
1990 Standout

Author Peers

Author Last Decade Papers Cites
D G Altman 1293 675 875 1077 24 7.7k
Karmela Krleža-Jerić 1164 652 1330 689 18 8.1k
Diana R Elbourne 1007 831 2059 1040 21 10.4k
Roman Jaeschke 1596 1041 949 735 43 7.1k
John Concato 862 602 852 501 38 6.0k
Harry Smith 1350 548 821 1016 117 7.1k
Henry S. Sacks 1423 583 994 1305 94 8.2k
Ba’ Pham 1034 543 708 1006 61 5.8k
Mark Simmonds 943 359 1895 671 64 6.5k
Klaus‐Peter Schulz 766 461 684 977 14 4.8k
Kerry Dwan 666 804 1143 1628 101 6.9k

All Works

Loading papers...

Rankless by CCL
2026